DCM
DGS Capital Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $956K | Sell |
28,268
-6,170
| -18% | -$209K | 0.24% | 76 |
|
|
2024
Q3 | $1.41M | Buy |
34,438
+1,304
| +4% | +$53.3K | 0.38% | 46 |
|
|
2024
Q2 | $1.28M | Buy |
33,134
+2,443
| +8% | +$94.1K | 0.36% | 45 |
|
|
2024
Q1 | $1.32M | Buy |
30,691
+466
| +2% | +$20K | 0.37% | 38 |
|
|
2023
Q4 | $1.12M | Sell |
30,225
-7,238
| -19% | -$268K | 0.43% | 38 |
|
|
2023
Q3 | $1.36M | Buy |
37,463
+4,403
| +13% | +$160K | 0.66% | 25 |
|
|
2023
Q2 | $1.18M | Buy |
33,060
+5,220
| +19% | +$186K | 0.59% | 30 |
|
|
2023
Q1 | $991K | Buy |
27,840
+4,893
| +21% | +$174K | 0.55% | 32 |
|
|
2022
Q4 | $806K | Buy |
22,947
+9,503
| +71% | +$334K | 0.53% | 42 |
|
|
2022
Q3 | $396K | Buy |
13,444
+7,238
| +117% | +$213K | 0.26% | 83 |
|
|
2022
Q2 | $270K | Buy |
+6,206
| New | +$270K | 0.22% | 122 |
|